Antifungal therapy could be key to asthma treatment

May 9th, 2013

An estimated 4,837,000 asthmatics with allergic bronchopulmonary aspergillosis (ABPA) could benefit substantially from antifungal treatment, say researchers from the University of Toronto and Manchester University.


A reproduction of a lithograph plate from Gray's Anatomy. Image: WIkimedia Commons.


Comments are closed.